Drugs Controller General of India
-
India’s first mRNA vaccine from Gennova gets DCGI approval
To be sold under the brand name GEMCOVAC-19 Gennova Biopharmaceuticals, a subsidiary of Emcure Pharmaceuticals, announced that its mRNA vaccine…
Read More » -
AstraZeneca’s Dapagliflozin tabs get DCGI nod
The drug will be used for patients with chronic kidney disease AstraZeneca Pharma India has received approval from the Drugs…
Read More » -
Experts underscore uncertainty about AstraZeneca’s dosage and efficacy
According to experts, the vaccine developed by AstraZeneca and Oxford University showed only 62.1 per cent efficacy, much lower than…
Read More » -
Bangladesh to receive India’s vaccine by end of this month: Foreign Minister
According to the minister, SII is obligated to provide 30 million doses by late January or early February under a…
Read More » -
Bharat Biotech plans to launch vaccine candidate in second quarter of 2021
The trial will be conducted in 25 sites in 10-12 states Bharat Biotech is planning to launch its COVID-19 vaccine…
Read More »